Today (10/20) AmacaThera was granted approval from Health Canada to send their post-operative long-term anesthetic into phase one of clinical trial. This is the first drug they have sent through the clinical trial phase a milestone for the company. AmacaThera was funded by Lumira Ventures, Sprout Bioventures, and Grey Sky Venture Partners, early stage investment funding parteners in the field.
Read more here.
More on: News Regulatory
Don’t miss the next article from HealthFirst 100.
Join our mailing list to receive the latest posts from our blog directly in your inbox.